- CA$593.54m
- CA$562.64m
- CA$152.42m
- 96
- 10
- 92
- 72
2019 April 30th | 2020 April 30th | 2021 April 30th | 2022 April 30th | 2023 April 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 76.4 | 105 | 123 | 137 | 152 |
Cost of Revenue | |||||
Gross Profit | 37.4 | 50.3 | 60.6 | 60.3 | 66.8 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 78.2 | 100 | 112 | 131 | 149 |
Operating Profit | -1.8 | 4.71 | 10.7 | 5.95 | 3.57 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -1.76 | 3.58 | 10.4 | 5.42 | 3.71 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.741 | 2.35 | 7.19 | 4.48 | 2.09 |
Net Income Before Extraordinary Items | |||||
Net Income | -0.741 | 2.35 | 7.19 | 4.48 | 2.09 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.741 | 2.35 | 7.19 | 4.48 | 2.09 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.057 | 0.265 | 0.486 | 0.269 | 0.141 |
Dividends per Share |